This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Shim, W. S.N. Articles by Wong, P. E.H. Search for Related Content PubMed PubMed Citation Articles by Shim, W. S.N. Articles by Wong, P. E.H. Related Collections Tumor Biology Tumor Biology: Angiogenesis

---

Subject Review

Angiopoietin: A TIE(d) Balance in Tumor Angiogenesis

¹ Research and Development Unit, National Heart Centre; ² Department of Surgery, National University of Singapore; and ³ Laboratory of Cancer Gene Therapy, National Cancer Centre, Singapore, Singapore

Requests for reprints: Winston S.N. Shim, Research and Development Unit, National Heart Centre, 17 Third Hospital Avenue, Singapore 168752, Singapore. Phone: 65-6435-0752. E-mail: surssnw{at}nus.edu.sg

Abstract

Angiopoietins (ANG-1 and ANG-2) and their TIE-2 receptor tyrosine kinase have wide-ranging effects on tumor malignancy that includes angiogenesis, inflammation, and vascular extravasation. These multifaceted pathways present a valuable opportunity in developing novel inhibition strategies for cancer treatment. However, the regulatory role of ANG-1 and ANG-2 in tumor angiogenesis remains controversial. There is a complex interplay between complementary yet conflicting roles of both the ANGs in shaping the outcome of angiogenesis. Embryonic vascular development suggests that ANG-1 is crucial in engaging interaction between endothelial and perivascular cells. However, recruitment of perivascular cells by ANG-1 has recently been implicated in its antiangiogenic effect on tumor growth. It is becoming clear that TIE-2 signaling may function in a paracrine and autocrine manner directly on tumor cells because the receptor has been increasingly found in tumor cells. In addition, ₅ß₁ and _vß₅ integrins were recently recognized as functional receptors for ANG-1 and ANG-2. Therefore, both the ligands may have wide-ranging functions in cellular activities that affect overall tumor development. Collectively, these TIE-2–dependent and TIE-2–independent activities may account for the conflicting findings of ANG-1 and ANG-2 in tumor angiogenesis. These uncertainties have impeded development of a clear strategy to target this important angiogenic pathway. A better understanding of the molecular basis of ANG-1 and ANG-2 activity in the pathophysiologic regulation of angiogenesis may set the stage for novel therapy targeting this pathway. (Mol Cancer Res 2007;5(7):655–65)

This article has been cited by other articles:

				G. C. Prendergast Recent Movement to Exploit Key Signaling Molecules and Cancer Vaccines Cancer Reviews Online Content, August 1, 2007; 2007(5): 9 - 9. [Full Text] [PDF]